31 Mar 2021
Assets99.26
Total Income193.73
Profit After Tax2.67
NET Worth22.51
Reserves and Surplus12.96
Total Borrowing29.77
Open 9th Mar 2023 · Close 14th Mar 2023 · Listing 22nd Mar 2023
Sudarshan Pharma Industries is a SME IPO with an issue size of ₹50.10 crore, proposed for listing on BSE SME. The offer opens on 9th Mar 2023 and closes on 14th Mar 2023. The issue structure includes a fresh issue of ₹47.58 crore.
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 1600 | ₹116,800 |
| Object | Amount |
|---|---|
| To set up a dedicated manufacturing facility for Pharmaceutical Business | ₹12.50 Cr |
| Distribution and Warehousing Centre‘s & Purchase of Corporate Office | ₹4.50 Cr |
| Additional Working Capital | ₹5.25 Cr |
| General Corporate Expenses | ₹2.80 Cr |
| KPI |
|---|
| ROE |
| ROCE |
| Debt / Equity |
| RoNW |
| PAT Margin |
| Expense | Amount |
|---|---|
| Lead Manger Fees including Underwriting Commission | ₹0.18 Cr |
| Market Making Charges for first year of Listing | ₹0.04 Cr |
| Fees Payable to Registrar to the Issue | ₹0.01 Cr |
| Fees Payable to Advertising and Marketing Expenses | ₹0.35 Cr |
| Fees Payable to Regulators including Stock Exchanges | ₹0.02 Cr |
| Payment for Printing & Stationery, Distribution, Postage, etc | ₹0.02 Cr |
| Others (Fees Payable to Peer Review Auditor, Fees to Legal Advisors, Marketing Expenses, Brokerage, Processing Fees for Application and Miscellaneous Expenses) | ₹0.14 Cr |